Literature DB >> 11293492

Development of glaucoma in the course of interferon alpha therapy for chronic hepatitis B.

Y S Kwon1, Y H Choe, H S Chin.   

Abstract

Previous reported ocular complications of interferon alfa administration are extremely rare. These include oculomotor palsy, corneal allograft rejection, retinal hemorrhage and cotton wool patches. A 15-year-old boy with chronic hepatitis B was treated with interferon alpha for six months, and then developed glaucoma. After the interferon therapy had been discontinued the glaucoma improved. Accordingly, we report a case of glaucoma development during the course of interferon alpha therapy for chronic hepatitis B.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11293492     DOI： 10.3349/ymj.2001.42.1.134

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN： 0513-5796            Impact factor:   2.759


  10 in total

Review 1.  Aicardi-Goutières syndrome and the type I interferonopathies.

Authors:  Yanick J Crow; Nicolas Manel
Journal:  Nat Rev Immunol       Date:  2015-06-05       Impact factor: 53.106

2.  The Collaborative Lifestyle Intervention Program in Knee Osteoarthritis Patients (CLIP-OA) trial: Design and methods.

Authors:  Brian C Focht; W Jack Rejeski; Kevin Hackshaw; Walter T Ambrosius; Erik Groessl; Zachary L Chaplow; Victoria R DeScenza; Jessica Bowman; Ciaran M Fairman; Beverly Nesbit; Kathryn Dispennette; Xiaochen Zhang; Marissa Fowler; Marcy Haynam; Stephanie Hohn
Journal:  Contemp Clin Trials       Date:  2022-03-11       Impact factor: 2.261

3.  Optineurin regulates the interferon response in a cell cycle-dependent manner.

Authors:  Pierre Génin; Frédérique Cuvelier; Sandrine Lambin; Josina Côrte-Real Filipe; Elodie Autrusseau; Christine Laurent; Emmanuel Laplantine; Robert Weil
Journal:  PLoS Pathog       Date:  2015-04-29       Impact factor: 6.823

4.  How often are major blood-borne pathogens found in eye patients? A serosurvey at an eye hospital in Southern China.

Authors:  Fang Duan; Qiang Huang; Jingyu Liao; Dajun Pang; Xiaofeng Lin; Kaili Wu
Journal:  PLoS One       Date:  2013-09-04       Impact factor: 3.240

5.  AFP and CA-125 as an accurate risk factor to predict eye metastasis in hypertension patients with liver carcinoma: A STROBE-compliant article.

Authors:  Jing Tang; Li-Juan Zhang; Min Kang; Rong Huang; Hui-Ye Shu; Hong Wei; Jie Zou; Yi-Cong Pan; Qian Ling; Yi Shao
Journal:  Front Genet       Date:  2022-09-19       Impact factor: 4.772

6.  Retinopathy associated with interferon therapy in patients with hepatitis C virus.

Authors:  Mahmoud Abd El-Badie Mohamed; Khaled Abd-El Azeem Eed
Journal:  Clin Ophthalmol       Date:  2012-08-20

7.  Interferon-gamma (IFN-γ)-mediated retinal ganglion cell death in human tyrosinase T cell receptor transgenic mouse.

Authors:  Shahid Husain; Yasir Abdul; Christine Webster; Shilpak Chatterjee; Pravin Kesarwani; Shikhar Mehrotra
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 8.  Ocular toxicity of systemic anticancer chemotherapy.

Authors:  Afekhide Ernest Omoti; Caroline Edijana Omoti
Journal:  Pharm Pract (Granada)       Date:  2006-04

Review 9.  Type I interferon-mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview.

Authors:  Mathieu P Rodero; Yanick J Crow
Journal:  J Exp Med       Date:  2016-11-07       Impact factor: 14.307

Review 10.  Ocular side effects of antirheumatic medications: a qualitative review.

Authors:  Clara M Castillejo Becerra; Yue Ding; Beatrice Kenol; Andrew Hendershot; Alexa Simon Meara
Journal:  BMJ Open Ophthalmol       Date:  2020-01-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.